The Epstein-Barr virus is one of the most common and persistent human viruses in the world, according to the CDC.

Scientists at UMC Utrecht have developed a new technology to efficiently isolate a specific subset of gut bacteria from fecal samples that are recognized by IgA antibodies. These "IgA-coated" bacteria ...

A new study of more than 150 COVID-19 patients shows that IgA antibodies dominate the early response to the SARS-CoV-2 virus, coming on more quickly and strongly than IgG and IgM antibodies.

The acquisition combines IgA antibody assets and expertise of Boston-based TigaTx with Epsilogen’s assets and expertise in IgE to create the world’s leading pan-isotype cancer antibody company ...

Scientists found that this bacteria would strip IgA antibody of its sugar in mice altered to carry human immune genes and in human cells grown in the lab, leaving the antibody in the same form ...

Antibodies to erythrocytes or leukocytes could not be found, but a precipitating antibody reactive with IgA in donor and normal human serum was discovered in the patient's serum.

An IgA anti-transglutaminase 2 (TGA-IgA) antibody cut-off of approximately 6.1 times the upper limit of normal optimised celiac disease diagnosis in children and adolescents with type 1 diabetes ...

Immunoglobulin A (IgA) nephropathy, also called Berger’s disease, is an autoimmune disease that affects your kidneys. IgA is an antibody. Antibodies are proteins made by your immune system. They ...

Felzartamab, an investigational antibody, reduces triggers linked to IgA nephropathy, an autoimmune kidney disease, suggesting lasting clinical benefits.

Meanwhile, TigaTx, which has been flying under the radar until now, is contributing TIGA-001 (now renamed EPS 401), an anti-EGFR IgA antibody with studies underway to prepare for human trials in 2026.